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The pathogenesis of psoriasis is not fully understood, but
population and twin studies suggest a large heritable
component to the etiology. Several large population
studies have also suggested a parental sex effect. Since
1994, three main genetic loci (on chromosomes 17q, 4q,
and 6p) have been reported in genome scans. With a
view to elucidating the genetic basis of psoriasis, we have
carried out linkage analysis in a large number of families
with well-characterized psoriasis. From a cohort of 1250
probands with psoriasis, 395 individuals (301 affected, 94
unaffected) in 103 families were recruited. Each subject
was carefully examined by an experienced dermatologist
and stringent diagnostic criteria applied. Genotypes were
generated at 11 polymorphic loci on chromosomes 17q,
4q, and 6p and the results were analyzed parametrically
and nonparametrically. In the population from which the
Psoriasis is a chronic relapsing disease affecting the skin andjoints of about 2% of the population (Lomholt, 1963).While rarely fatal, it causes substantial morbidity (Finlayet al, 1990) and the cost to society in economic terms isgreat (Sander et al, 1993). The molecular basis of psoriasis
has eluded sustained scientific enquiry. As there is clear evidence from
population and twin studies of a strong heritable component to the
etiology (Elder et al, 1994), attention has recently focused on possible
genetic determinants. The study of candidate genes has been largely
fruitless; however, the results of four genome scans have been reported
since 1994 (Tomfohrde et al, 1994; Matthews et al, 1996; Trembath
et al, 1997; Nair et al, 1997). These have yielded different linked
regions notably on chromosomes 17q, 4q, and 6p. There are many
statistical problems in the interpretation of linkage data obtained from
genome scans when the mode of inheritance is complex. The accepted
criteria are that a significant linkage may be declared if a LOD score
of greater than 3.3 is obtained and the results can be repeated in a
second independent cohort (Lander and Kruglyak, 1995).
A possible clue to the nature of the genes underlying psoriasis is the
observation in most large population studies of a parental sex effect
(Lomholt, 1963; Farber and Nall, 1974; Swanbeck et al, 1994), as seen
in some diseases caused by an unstable trinucleotide repeat mutation
(Hall, 1997). Such mutations may also result in genetic anticipation,
that is to say, an increase in disease severity or a decrease in age at
onset in successive generations.
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probands were drawn, there was evidence of a parental
sex effect, more probands having an affected father
than an affected mother. Genetic anticipation was also
apparent and most marked if the disease was inherited
from the father. The loci on chromosomes 17 and 4 were
not replicated but there was strong evidence for linkage
to chromosome 6p (maximum two point LOD score
4.63 at D6S291). The evidence for linkage in sibling pair
analysis was greatest when the allele was of paternal
origin and was most significant in those families without
psoriatic arthritis. These studies confirm the presence of
a susceptibility gene on chromosome 6p. The available
evidence suggests that a different genetic susceptibility
may underlie psoriasis and psoriatic arthritis. Key words:
anticipation/arthritis/linkage/paternal effect. J Invest Dermatol
110:958–960, 1998
We have studied the positional candidate regions previously reported
in a large collection of carefully examined psoriasis families in order
to establish whether the three reported loci underlie susceptibility to
psoriasis in a different population. We have also analyzed the pattern
of inheritance of psoriasis for evidence of genetic anticipation and a
parental sex effect.
MATERIALS AND METHODS
Family recruitment One thousand two hundred and fifty unselected
probands with psoriasis were identified from dermatology outpatient departments
throughout Scotland. Seven hundred and sixty-four responded to a questionnaire
concerning family involvement. Forty per cent of respondents reported that a
first degree relative was also affected. From this cohort, 103 families containing
395 individuals (301 affected, 94 unaffected) were recruited. Each individual
was carefully examined by one of two experienced dermatologists (ADB or
DT) and only those with unequivocal signs of plaque psoriasis at the time of
the examination were scored as ‘‘affected.’’ Involvement of the scalp alone was
not allowable. Involvement of the nails alone was not sufficient. Isolated pustular
eruptions of the palms and soles were designated palmoplantar pustulosis and
were not included. Involvement of seborrhoeic sites was included only if
accompanied by plaque psoriasis elsewhere. Those with equivocal signs (for
instance, scalp involvement alone) or an unconfirmed history of psoriasis were
scored as ‘‘unknown’’ and were excluded from linkage analysis. Early onset
psoriasis was mainly studied. The median age at onset (defined as the age at
which the subject first noticed the presence of psoriasis) was 20 y. Two hundred
and eighty-one of the affected subjects were under 40 y of age at onset of
the disease.
Sixty-four individuals in 46 families also had features of psoriatic arthritis,
defined as the presence of both psoriasis and inflammatory joint disease for
which no other cause was evident.
The families recruited contained 61 affected parent–child pairs (29 father–
child and 32 mother–child pairs). For these, the age at onset in each generation
and the parental age at birth were analyzed.
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Table I. Two point LOD scores with markers on chromosomes 6p, 17q, and 4q
Recombination fraction (θ)
Marker 0.00 0.01 0.05 0.1 0.2 0.3 0.4 θ max Z max
D6S273 26.61 24.16 0.07 1.97 2.70 1.96 0.83 0.182 2.73
D6S291 20.24 1.41 3.89 4.61 3.95 2.37 0.83 0.112 4.63
D6S426 28.28 25.61 20.67 1.67 2.67 1.92 0.79 0.188 2.68
D17S784 266.97 239.71 221.71 212.82 24.80 21.46 20.21 0.5 0
D4S1535 25.50 24.41 22.49 21.21 0.09 0.47 0.34 0.29 0.47
D4S171 26.41 25.48 23.58 22.18 20.61 0.03 0.15 0.36 0.17
D4S1652 25.46 24.57 22.98 21.93 20.77 20.22 20.01 0.47 0.00
Genotyping DNA was extracted from peripheral blood by phenol-chloro-
form extraction. Eleven polymorphic microsatellite repeats were typed as
follows: chromosome 6 (D6S422, D6S299, D6S265, TNF-a, D6S273, D6S291,
D6S426), chromosome 4 (D4S1535, D4S171, D4S1652), and chromosome 17
(D17S784). DNA was amplified by the polymerase chain reaction under
standard conditions for 25 cycles. Each 25 µl reaction mix contained 40 ng of
genomic DNA and primers were fluorescently labeled. Alleles were resolved
on polyacrylamide gels run on a ABI 373 semiautomated sequencer.
As the previously reported linkage to markers on chromosome 4 occurred
in a set of large pedigrees selected for psoriasis that appeared to segregate as an
autosomal dominant trait (Matthews et al, 1996), the eight three-generation
families in our cohort that also appeared to show dominant inheritance were
genotyped at the markers on chromosome 4. These pedigrees contained 99
individuals, 51 of whom were affected. The founders of the largest pedigree
(43 individuals, 17 affected) were Irish, as were most of the families in Matthews
reported linkage (Matthews et al, 1996).
Linkage analysis As the pattern of inheritance of psoriasis is unknown,
results were analyzed both parametrically and nonparametrically. Two point
linkage analysis was carried out with FASTLINK 2.3P (Lathrop et al, 1984)
under eight assumed genetic models. Two models were recessive and six were
dominant with penetrance ranging from 50% to 99% and the phenocopy rate
from 0 to 5% and including affecteds-only analyses. The HOMOG and MTEST
programs were used to test for locus heterogeneity (Ott, 1991).
As parametric analysis is sensitive to misspecification of the genetic model,
affected sibling pair analyses (using the GAS programs) were employed. By this
method, deviation from the expected pattern of allele sharing between affected
siblings at a particular locus is examined.
Simulations To determine whether the pedigrees were of a suitable size and
structure to detect linkage if present, computer simulations using the SLINK
program were carried out (Weeks et al, 1990). A marker at a recombination
fraction of 0.04 from the disease gene was simulated and linkage analysis carried
out on the resulting genotypes. The process was repeated 1000 times and an
average LOD score (ELOD) was calculated.
RESULTS
Paternal effect Of the 764 individuals who responded to the initial
questionnaire, 13% had an affected father and 11% had an affected
mother (p 5 0.044). The mean age at onset in an affected father was
24.1 y older than the age at onset in his offspring (37.1 y against 13 y),
whereas for an affected mother the difference was 10.9 y (20 y against
30.9 y). The difference in age at onset when inherited from an
affected father or an affected mother was statistically significant (two
sample t test of T 5 –2.71, p 5 0.009; the difference in age at onset
was normally distributed). There was no correlation between parental
age at conception and the age at onset in the offspring.
Simulations When analyzed under dominant models, the expected
LOD score (ELOD) lay between 15.5 and 11.5 and the ELOD score
was greater than three in each of the 1000 replicates. When 50%
heterogeneity was introduced the ELOD fell to 4.5 and the LOD
score was greater than three in 67% of replicates.
Linkage studies Parametric analysis provided strong evidence for
linkage at loci on chromosome 6 that maximized at D6S291. The
maximum two point LOD score was 4.63 under a dominant model
with 70% penetrance and 5% phenocopies (Table I). No evidence for
locus heterogeneity was demonstrated with HOMOG. Affected sibling




Marker siblings 0 1 2 p value
D6S273 61 17.3 50.0 32.7 0.04
D6S291 50 10.0 59.0 31.0 0.006
D6S426 78 16.4 53.0 30.6 0.02
pair analyses supported linkage (Table II) and the distortion of allele
sharing was maximal when the allele was of paternal origin (Table III).
The parametric analysis at D17S784 excluded linkage to beyond a
recombination fraction of 0.25 (35 cM Haldane) with the genetic
model under which linkage has previously been reported (Tomfohrde
et al, 1994) (Table I), i.e., dominant inheritance, 99% penetrance, and
no phenocopies. No evidence for linkage under any other model was
obtained. Affected sibling pair analyses revealed no distortion of allele
sharing at D17S784. Two point linkage analysis (Table I) and sibling
pair analyses revealed no evidence for linkage to the locus on
chromosome 4.
Psoriatic arthritis Two point linkage analysis with the marker on
chromosome 6 that showed the strongest linkage to the entire set of
families (D6S291) was repeated with two groups of families divided
according to whether they contained individuals with psoriatic arthritis.
Those without psoriatic arthritis gave a maximal LOD score of 3.64
at D6S291 (Table IV), whereas those with psoriatic arthritis showed
no significant evidence for linkage to this marker. The difference in
LOD scores between the two groups was significant using the MTEST
(p 5 0.019).
DISCUSSION
With the discovery of unstable trinucleotide repeat mutations, there is
great interest in diseases showing evidence for genetic anticipation or
a parental sex effect. Whilst this type of mutation has as yet only been
detected in diseases with a dominant neuro-muscular involvement,
some epidemiologic features of genetic anticipation have recently been
demonstrated in Crohn’s disease (Polito et al, 1996), a disease that is
statistically associated with psoriasis (Yates et al, 1982; Hughes et al,
1983). A paternal effect has been suggested in many large population
studies of psoriasis (Lomholt, 1963; Farber and Nall, 1974; Swanbeck
et al, 1994) and, although frequently not reaching statistical significance,
the trend is always in the same direction. We have demonstrated a
statistically significant paternal effect and provided the first evidence of
genetic anticipation with greater intergenerational reduction in age at
onset when the disease is inherited from the father. It is now possible
to look for molecular evidence of an unstable trinucleotide repeat by
the repeat expansion detection system (Schalling et al, 1993).
The importance of independent replication of linkages in genome
scans has frequently been stated (Lander and Kruglyak, 1995), but in
practice has been difficult to obtain. Reasons for this include type 1
statistical errors produced by the multiple testing inherent in a genome
scan and the problems of defining a significance level that is robust
and yet sensitive to the effects of minor disease loci. In a replication
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Table III. Paternal and maternal alleles shared by affected siblings at markers on chromosome 6p
Paternally derived allele (%) Maternally derived allele (%)
Marker No. of siblings Shared p value No. of siblings Shared p value
D6S273 38 76.3 0.00083 32 50.0 0.5
D6S291 30 75.0 0.021 29 47.4 0.5
D6S426 32 68.2 0.067 36 57.7 0.28
Table IV. MTEST for psoriatic arthritis at D6S291
Estimated recombination fraction
Family type 0 0.01 0.05 0.1 0.2 0.3 0.4
Psoriatic arthritis present 24.41 22.76 0.07 1.30 1.71 1.24 0.49
Psoriatic arthritis not present 3.64 3.51 3.30 2.87 1.92 1.03 0.36
Total 20.77 0.75 3.37 4.17 3.63 2.27 0.85
study, as this involves testing a prior hypothesis, a nominal p value of
0.01 is sufficient to give an interval wide significance level of 5%
(Lander and Kruglyak, 1995). Type 1 statistical error may in part
contribute to the inability to replicate the linkage to chromosome 4
in which the evidence for linkage in the initial report was close to the
significance levels that the authors set (Matthews et al, 1996). The
linkage to chromosome 17 on the other hand was supported by a
LOD score of 5.33, making a false positive result less probable. Several
failed attempts to replicate this result may have lacked sufficient power
to detect even a fairly major gene (Matthews et al, 1995; Botta et al,
1996). The linkage information available in the large cohort of families
in this report is substantial, yielding an estimated LOD score under
simulation of 15.5 with the genetic model under which linkage was
originally detected on chromosome 17 (Tomfohrde et al, 1994);
however, when genetic locus heterogeneity is introduced, the power
to detect a linkage falls substantially. The LOD score in Tomfohrde’s
study was maximal under the assumption that 50% of the families
were linked (Tomfohrde et al, 1994). If such a degree of heterogeneity
were present in the families reported here, the ELOD is reduced to
4.5 and falls rapidly as heterogeneity increases. It has been suggested
that the linkage to chromosome 17q may be more relevant to families
with psoriasis and arthritis (Bowcock, 1995), as psoriatic arthritis was
over-represented in the large family in which linkage was initially
detected; however, when linkage analysis was carried out in our families
with and without psoriatic arthritis separately, there was no detectable
difference between the two groups (data not shown). We can therefore
provide no support for this hypothesis.
Linkage to chromosome 6 is the first genetic locus in psoriasis to
be independently replicated. The linkage extends over a wide genetic
distance but the HLA region is the primary positional candidate given
the strong association between psoriasis and HLA Cw6 that has been
known since the late 1970s (Batchelor and Morris, 1977). The distortion
of sharing of paternally derived alleles at markers on chromosome 6p
is reminiscent of the early findings in genome scans in insulin dependent
diabetes mellitus (Julier et al, 1991), and the differential parental
transmission of HLA alleles in insulin dependent diabetes mellitus may
be relevant in this context (Deschamps et al, 1990). In a further
independent cohort of 900 probands with psoriatic arthritis we have
found no evidence for a paternal effect (data not shown). The suggestion
that linkage to chromosome 6 is less evident in those families with
psoriatic arthritis in addition to cutaneous psoriasis, and the lack of a
parental sex effect in psoriatic arthritis, are compatible with a major
gene for cutaneous psoriasis close to the HLA region, inherited
paternally. Early HLA association studies suggested a greater role for
genetic determinants outside the HLA region in psoriatic arthritis
compared with psoriasis (Woodrow and Ilchysyn, 1985). Psoriatic
arthritis may therefore be an informative disease in a genome scan
both in its own right and as a means to shed further light on the
genetic determinants of cutaneous psoriasis.
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